Hydrochloric Acid

Hydrochloric Acid

SCHEMBL5144072

CCN1CC[N+](CC)=C1Cl.[Cl-]

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
FURIN P09958 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
NPC1 O15118 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
NR2F2 P24468 1/20 0.33
HTT P42858 1/20 0.33
RAB9A P51151 1/20 0.33
RUNX1 Q01196 1/20 0.33
KMT2A Q03164 1/20 0.33
CBFB Q13951 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24233131 0.98 FURIN (0.34) FURINKDM4EMEN1NPC1ALDH1A1
Bromide SCHEMBL4652927 0.96 FURIN (0.33) FURINKDM4EMEN1NPC1ALDH1A1
Iodide SCHEMBL7222757 0.96 KDM4E (0.36) FURINKDM4EMEN1NPC1ALDH1A1
Hydrochloric Acid SCHEMBL7222311 0.75 FURIN (0.33) FURINKDM4EMEN1NPC1ALDH1A1
SCHEMBL1901414 0.72 FURIN (0.34) FURINKDM4EMEN1NPC1ALDH1A1
SCHEMBL13814467 0.71 FURIN (0.33) FURINKDM4EMEN1NPC1ALDH1A1
Bromide SCHEMBL4652704 0.71 FURIN (0.33) FURINKDM4EMEN1NPC1ALDH1A1
Iodide SCHEMBL7218732 0.71 KDM4E (0.36) FURINKDM4EMEN1NPC1ALDH1A1
Hydrochloric Acid SCHEMBL7773582 0.71 EEF2K (0.31)
SCHEMBL24233140 0.68 EEF2K (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-10152550-A None JP disclosed
CN-107848963-B Acid-resistant alkali-producing agent and/or radical-producing agent, and curable resin composition containing same 富士胶片和光纯药株式会社 2020-11-03 CN disclosed
EP-3327002-B1 ACID-RESISTANT BASE AND/OR RADICAL GENERATOR, AND CURABLE RESIN COMPOSITION CONTAINING SAID BASE AND/OR RADICAL GENERATOR FUJIFILM WAKO PURE CHEMICAL CORP (JP) 2020-08-19 EP disclosed
US-10428015-B2 Acid-resistant base and/or radical generator, and curable resin composition containing said base and/or radical generator FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2019-10-01 US disclosed
US-20190002403-A1 ACID-RESISTANT BASE AND/OR RADICAL GENERATOR, AND CURABLE RESIN COMPOSITION CONTAINING SAID BASE AND/OR RADICAL GENERATOR FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2019-01-03 US disclosed
EP-3098226-B1 BORATE-BASED BASE GENERATOR, AND BASE-REACTIVE COMPOSITION COMPRISING SUCH BASE GENERATOR FUJIFILM WAKO PURE CHEMICAL CORP (JP) 2018-12-12 EP disclosed
US-10100070-B2 Borate-based base generator, and base-reactive composition comprising such base generator FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2018-10-16 US disclosed
EP-3327002-A1 ACID-RESISTANT BASE AND/OR RADICAL GENERATOR, AND CURABLE RESIN COMPOSITION CONTAINING SAID BASE AND/OR RADICAL GENERATOR Wako Pure Chemical Industries, Ltd. (JP) 2018-05-30 EP disclosed
EP-3098226-A1 BORATE-BASED BASE GENERATOR, AND BASE-REACTIVE COMPOSITION COMPRISING SUCH BASE GENERATOR Wako Pure Chemical Industries, Ltd. (JP) 2016-11-30 EP disclosed
US-20160340374-A1 BORATE-BASED BASE GENERATOR, AND BASE-REACTIVE COMPOSITION COMPRISING SUCH BASE GENERATOR FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2016-11-24 US disclosed
US-7273953-B2 Process for producing arylamine FUJIFILM FINECHEMICALS CO., LTD. (JP) 2007-09-25 US disclosed
US-20060069287-A1 Process for producing arylamine FUJIFILM FINECHEMICALS CO., LTD. (JP) 2006-03-30 US disclosed
US-6939966-B2 Radiolabeled neuropeptide Y Y5 receptor antagonists MERCK & CO., INC. (US) 2005-09-06 US disclosed
US-20040192705-A1 Radiolabeled neuropeptide y y5 receptor antagonists MERCK SHARP & DOHME CORP. 2004-09-30 US disclosed
EP-0769512-B1 Process for preparing polycondensation polymers using haloiminium salts as condensation agents MITSUI CHEMICALS INC (JP) 2001-07-18 EP disclosed
US-5892061-A REACTING A MONO- OR POLYCARBOXYLIC ACID WITH A MONO- OR POLYAMIDE IN THE PRESENCE OF A HALOIMINIUM SALT AND BASE; CATALYST SELECTIVITY MITSUI CHEMICALS, INC. (JP) 1999-04-06 US disclosed
EP-0846714-A1 Preparation process of isoimide Mitsui Chemicals, Inc. (JP) 1998-06-10 EP disclosed
JP-H10152550-A PRODUCTION OF POLYCONDENSATION POLYMER MITSUI CHEM INC 1998-06-09 JP disclosed
US-5719256-A CONDENSING CARBOXYL GROUP CONTAINING COMPOUND AND ACTIVE HYDROGEN CONTAINING COMPOUND IN PRESENCE OF HALOIMINIUM SALT AS POLYMERIZATION CATALYST MITSU TOATSU CHEMICALS, INC. (JP) 1998-02-17 US disclosed
EP-0769512-A2 Process for preparing polycondensation polymers MITSUI TOATSU CHEMICALS, INC. (JP) 1997-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10428015-B2 Acid-resistant base and/or radical generator, and curable resin composition containing said base and/or radical generator REV1, RER1, CBR1 FURIN 2950/4885KDM4E 2400/4885MEN1 1882/4885
US-10100070-B2 Borate-based base generator, and base-reactive composition comprising such base generator BLM, HPRT1, BROX FURIN 374/4885KDM4E 4758/4885MEN1 28/4885
US-20060069287-A1 Process for producing arylamine TYR, AADAC, AOC2 FURIN 3467/4885KDM4E 1302/4885MEN1 3458/4885
US-20190002403-A1 ACID-RESISTANT BASE AND/OR RADICAL GENERATOR, AND CURABLE RESIN COMPOSITION CONTAINING SAID BASE AND/OR RADICAL GENERATOR REV1, RER1, CBR1 FURIN 2950/4885KDM4E 2400/4885MEN1 1882/4885
US-20160340374-A1 BORATE-BASED BASE GENERATOR, AND BASE-REACTIVE COMPOSITION COMPRISING SUCH BASE GENERATOR ENPP3, GNG2, ENPP1 FURIN 3487/4885KDM4E 3364/4885MEN1 975/4885
US-20040192705-A1 Radiolabeled neuropeptide y y5 receptor antagonists NPY5R, NPY1R, SSTR5 FURIN 1748/4885KDM4E 1919/4885MEN1 865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.